News
What’s new at Myllia — announcements, publications and partnerships from our CRISPR screening team in Vienna.
Meet the speaker #3 | Perturb 2027
Associate Professor at Stanford University, get to know Dr. Anshul Kundaje and learn about his research with machine learning models of gene regulation.
Meet the speaker #2 | Perturb 2027
Earning his PhD from the University of Washington, Dr. Junyue Cao went on to lead the Laboratory of Single-Cell Genomics and Population Dynamics at The Rockefeller University. Learn more about his career path.
Meet the speaker #1 | Perturb 2027
With a career that includes directing the Icahn Genomics Institute and vice-chairing the Department of Immunology & Immunotherapy at the Mount Sinai Medical Center, get to know more about Dr. Brian Brown's career.
Press Release: The State Model Publication in Cell 2026
A Landmark State Model Publication in Cell Positions Myllia Biotechnology as the Go-To Partner for Perturb-Seq Datasets in Primary Human Cells
Myllia launches image-based CRISPR screening for spatial target discovery
Element Biosciences and Myllia Biotechnology demonstrate successful multimodal optical pooled screening for drug discovery
Press Release: Myllia launches “VISTA”, the macrophage and dendritic cell screening platform
The breakthrough VISTA™ platform opens new frontiers in drug target discovery and leverages sequencing technology from Ultima Genomics.